Effects of Zinc Supplementation in Patients with Major Depression: A Randomized Clinical Trial
-
Elham Ranjbar
,
Masoumeh Sabet Kasaei
,
Minoo Mohammad-Shirazi
,
Javad Nasrollahzadeh
,
Bahram Rashidkhani
,
Jamal Shams
,
Seyed-Ali Mostafavi
,
Mohammad Reza Mohammadi
Abstract
Objective: Major depression is a mood disorder that causes changes in physical activity, appetite, sleep and weight. Regarding the role of zinc in the pathology of depression, the present study was aimed to investigate the effects of zinc supplementation in the treatment of this disease.
Methods: This study was a double-blind randomized clinical trial. Forty four patients with major depression were randomly assigned to groups receiving zinc supplementation and placebo. Patients in Zinc group received daily supplementation with 25 mg zinc adjunct to antidepressant; Selective Serotonin Reuptake Inhibitors (SSRIs), while the patients in placebo group received placebo with antidepressants (SSRIs) for twelve weeks. Severity of depression was measured using the Beck Depression Inventory at baseline and was repeated at the sixth and twelfth weeks. ANOVA with repeated measure was used to compare and track the changes during the study .
Results: The mean score of Beck test decreased significantly in the zinc supplemen group at the end of week 6 (P<0.01) and 12 (P<0.001) compared to the baseline. The mean score of Beck Depression Inventory reduced significantly compared to the placebo group at the end of 12th week (P<0.05)
Conclusion: The results of the present study indicate that zinc supplementation together with SSRIs antidepressant drug improves major depressive disorders more effectively in patients with placebo plus antidepressants (SSRIs).
Kleinman A. Culture and depression. N Engl J Med 2004; 351: 951-3.
Dejman M, Ekblad S, Forouzan AS, Baradaran-Eftekhari M, Malekafzali H. Explanatory Model of Help-Seeking and Coping Mechanisms among Depressed Women in Three Ethnic Groups of Fars, Kurdish, and Turkish in Iran. Archives of Iranian medicine 2008; 11: 397-406.
Kaplan H, sadock B. Synopsis of psychiatry 8eds. williams and wilkins; 2003.
Fava M, Davidson KG. Definition and Epidemiology of Treatment-Resistant Depression. The Psychiatric clinics of North America 1996; 19: 179-200.
Hansen CR, Jr., Malecha M, Mackenzie TB, Kroll J. Copper and Zinc Deficiencies in Association with Depression and Neurological Findings. Biological psychiatry 1983; 18: 395-401.
Sandstead HH, Penland JG, Alcock NW, Dayal HH, Chen XC, Li JS, et al. Effects of Repletion with Zinc and Other Micronutrients on Neuropsychologic Performance and Growth of Chinese Children. The American journal of clinical nutrition 1998; 68: 470S-475S.
Amani R, Saeidi S, Nazari Z, Nematpour S. Correlation between Dietary Zinc Intakes and Its Serum Levels with Depression Scales in Young Female Students. Biological trace element research 2010; 137: 150-158.
McLoughlin IJ, Hodge JS. Zinc in Depressive Disorder. Acta psychiatrica Scandinavica 1990; 82: 451-453.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An Inventory for Measuring Depression. Archives of general psychiatry 1961; 4: 561-571.
Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Reference Values for Serum Zinc Concentration and Prevalence of Zinc Deficiency in Adult Iranian Subjects. Biological trace element research 2012; 149: 307-314.
Dabbaghmanesh MH, Taheri Boshrooyeh H, Kalantarhormozi MR, Ranjbar Omrani GH. Assessment of Zinc Concentration in Random Samples of the Adult Population in Shiraz, Iran. Iranian Red Crescent medical journal 2011; 13: 249-255.
Siwek M, Dudek D, Schlegel-Zawadzka M, Morawska A, Piekoszewski W, Opoka W, et al. Serum Zinc Level in Depressed Patients During Zinc Supplementation of Imipramine Treatment. Journal of affective disorders 2010; 126: 447-452.
schlegel_zawadzka M, Zieba A, Dudek D. effect of depression and of antidepressant therapy on serum zinc levels- a preliminary clinical study. New York: 2000.
McLoughlin IJ, Hodge JS. Zinc in Depressive Disorder. Acta psychiatrica Scandinavica 1990; 82: 451-453.
Ghasemi A, Zahediasl S, Hosseini-Esfahani F, Azizi F. Reference Values for Serum Zinc Concentration and Prevalence of Zinc Deficiency in Adult Iranian Subjects. Biological trace element research 2012; 149: 307-314.
White JW, Wolraich M. Effect of Sugar on Behavior and Mental Performance. The American journal of clinical nutrition 1995; 62: 242S-247S; discussion 247S-249S.
Buist R. The therapeutic predictability of tryptophan and tyrosine in the treatment of depression. Int J Clin Nutr Rev. 1983; 3: 1-3.
Kravitz HM, Sabelli HC, Fawcett J. Dietary Supplements of Phenylalanine and Other Amino Acid Precursors of Brain Neuroamines in the Treatment of Depressive Disorders. The Journal of the American Osteopathic Association 1984; 84: 119-123.
Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, et al. Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry. The Journal of clinical psychiatry 2006; 67: 1954-1967.
Fava M, Borus JS, Alpert JE, Nierenberg AA, Rosenbaum JF, Bottiglieri T. Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder. The American journal of psychiatry 1997; 154: 426-428.
Bell KM, Potkin SG, Carreon D, Plon L. S-Adenosylmethionine Blood Levels in Major Depression: Changes with Drug Treatment. Acta neurologica Scandinavica. Supplementum 1994; 154: 15-18.
Nowak G, Siwek M, Dudek D, Zieba A, Pilc A. Effect of Zinc Supplementation on Antidepressant Therapy in Unipolar Depression: A Preliminary Placebo-Controlled Study. Polish journal of pharmacology 2003; 55: 1143-1147.
Poleszak E, Wlaz P, Wrobel A, Fidecka S, Nowak G. Nmda/Glutamate Mechanism of Magnesium-Induced Anxiolytic-Like Behavior in Mice. Pharmacological reports : PR 2008; 60: 655-663.
Nowak G, Szewczyk B, Sadlik K, Piekoszewski W, Trela F, Florek E, et al. Reduced Potency of Zinc to Interact with Nmda Receptors in Hippocampal Tissue of Suicide Victims. Polish journal of pharmacology 2003; 55: 455-459.
Franco JL, Posser T, Brocardo PS, Trevisan R, Uliano-Silva M, Gabilan NH, et al. Involvement of Glutathione, Erk1/2 Phosphorylation and Bdnf Expression in the Antidepressant-Like Effect of Zinc in Rats. Behavioural brain research 2008; 188: 316-323.
Nowak G, Legutko B, Szewczyk B, Papp M, Sanak M, Pilc A. Zinc Treatment Induces Cortical Brain-Derived Neurotrophic Factor Gene Expression. European journal of pharmacology 2004; 492: 57-59.
| Files | ||
| Issue | Vol 8 No 2 (2013) | |
| Section | Articles | |
| Keywords | ||
| Major depressive disorder Zinc supplement placebo and Selective Serotonin Reuptake Inhibitors (SSRIs) | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
